Charles Schwab stands out among brokers for its customer service, $0 trade commissions and large selection of mutual funds. Commission-free stock, options and ETF trades. Five trading platforms ...

leverages changes in earnings projections to function as a reliable gauge for predicting short-term stock price movements. Charles River currently has a Zacks Rank #3 (Hold), indicating that it could ...

In a report released on November 7, Patrick B Donnelly from Citi maintained a Sell rating on Charles River Labs (CRL – Research Report).

Mizuho Securities analyst Ann Hynes has maintained their neutral stance on CRL stock, giving a Hold rating yesterday. Ann Hynes’s rating ...

Charles River Labs Q3 revenue of $1.01 billion surpassed expectations; however, revenue declined 1.6% YoY, and operating ...

Charles River Laboratories (CRL) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.72 per share a year ago.

WILMINGTON, Mass. (AP) — WILMINGTON, Mass. (AP) — Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $69.7 million. On a per-share basis, the ...

The consensus outlook from analysts is an Outperform trajectory for Repligen, with an average 1-year price target of $192.5, indicating a potential 224.68% upside.

Overall, analysts' consensus view on Charles River Laboratories stock is cautious, with a "Hold" rating. Out of 17 analysts covering the stock, five recommend a "Strong Buy," 10 suggest a "Hold ...

WELLINGTON, New Zealand — King Charles III told a summit of Commonwealth countries in Samoa that the past could not be changed as he indirectly acknowledged calls from some of Britain’s former ...